verapamil has been researched along with bufalin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, BB; Fang, FF; Gu, W; Huang, F; Li, B; Liu, L | 1 |
| Brenk, R; Efferth, T; Gruber, L; Kopp, B; Urban, E; Zehl, M; Zeino, M | 1 |
2 other study(ies) available for verapamil and bufalin
| Article | Year |
|---|---|
Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-X Protein; Bufanolides; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Survival; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Thymidylate Synthase; Verapamil | 2014 |
Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.
Topics: Antineoplastic Agents; Bufanolides; Cardiac Glycosides; Cell Line, Tumor; Cell Survival; Digoxin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression; Humans; Leukocytes, Mononuclear; Molecular Docking Simulation; Primary Cell Culture; Quantitative Structure-Activity Relationship; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Verapamil | 2015 |